Drawing for CYTO-JECT

USPTO serial 86201852

CYTO-JECT

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
GUSTASON, ANNE C
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CYTO-JECT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

William J. Sapone

WILLIAM J. SAPONE WARE FRESSOLA MAGUIRE & BARBER LLP755 Main Street, Bldg. 5P.O. Box 224MONROE, CT 06468

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for human and veterinary use for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; Pharmaceutical preparations for human and veterinary use for the treatment of inflammatory disorders; Pharmaceutical preparations for human and veterinary use for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations and substances for human and veterinary use for the prevention and treatment of infectious, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticalsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Oct 23, 2017MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 23, 2017ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 23, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 22, 2017EX5GSOU EXTENSION 5 GRANTED—
Mar 22, 2017AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 16, 2017EXT5SOU EXTENSION 5 FILED—
Mar 16, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 14, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 13, 2016EX4GSOU EXTENSION 4 GRANTED—
Sep 16, 2016EXT4SOU EXTENSION 4 FILED—
Sep 16, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 5, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 4, 2016EX3GSOU EXTENSION 3 GRANTED—
Apr 3, 2016AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 2, 2016EXT3SOU EXTENSION 3 FILED—
Mar 2, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 25, 2015EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 24, 2015EX2GSOU EXTENSION 2 GRANTED—
Sep 23, 2015AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Sep 14, 2015EXT2SOU EXTENSION 2 FILED—
Sep 14, 2015EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 14, 2015TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 17, 2015EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 13, 2015EX1GSOU EXTENSION 1 GRANTED—
Mar 13, 2015EXT1SOU EXTENSION 1 FILED—
Mar 13, 2015EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 16, 2014NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 22, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 10, 2014TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 3, 2014NPUBNOTICE OF PUBLICATION—
Jul 2, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 17, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 17, 2014ALIEASSIGNED TO LIE—
Jun 2, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 2, 2014XAECEXAMINER'S AMENDMENT ENTERED—
Jun 2, 2014GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 2, 2014GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 2, 2014CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 2, 2014DOCKASSIGNED TO EXAMINER—
Mar 7, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 27, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance